title: Generation of recombinant alphaviral vectors.
abstract: The alphaviruses Semliki Forest virus and Sindbis virus have been used frequently as expression vectors in vitro and in vivo. Usually, these systems consist of replication-deficient vectors that require a helper vector for packaging of recombinant particles. Replication-proficient vectors have also been engineered. Alphaviral vectors can be used as nucleic-acid-based vectors (DNA and RNA) or infectious particles. High-titer viral production is achieved in <2 d. The broad host range of alphaviruses facilitates studies in mammalian and nonmammalian cell lines, primary cells in culture, and in vivo. The strong preference for expression in neuronal cells has made alphaviruses particularly useful in neurobiological studies. Unfortunately, their strong cytotoxic effect on host cells, relatively short-term transient expression patterns, and the reasonably high cost of viral production remain drawbacks. However, novel mutant alphaviruses have showed reduced cytotoxicity and prolonged expression. Membrane proteins (which are generally difficult to express at high levels in recombinant systems) have generated high yields and facilitate applications in structural biology. Alphaviruses have also been applied in vaccine development and gene therapy. This protocol describes the production of recombinant alphaviral vectors. The SFV- and SIN-based expression systems apply two vectors for recombinant particle production. In addition to the RNA-based vectors described here, DNA vectors with cytomegalovirus or other RNA polymerase type II promoters can be used for direct plasmid DNA transfections. Cotransfection of SFV-based pSCA expression and pSCA helper vectors generates recombinant viral particles.
authors: Kenneth
authors: K
authors: Lundstrom
mesh_terms: D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D003587:Cytomegalovirus / Q000235:genetics; D004279:DNA, Viral / Q000235:genetics; D015870:Gene Expression; D005822:Genetic Vectors; D008967:Molecular Biology / Q000379:methods*; D009446:Neurobiology / Q000379:methods; D012367:RNA, Viral / Q000235:genetics; D011995:Recombination, Genetic; D012672:Semliki forest virus / Q000235:genetics* / Q000302:isolation & purification; D012845:Sindbis Virus / Q000235:genetics* / Q000302:isolation & purification; D014161:Transduction, Genetic; D014162:Transfection; D014765:Viral Vaccines / Q000235:genetics / Q000276:immunology
chemical_list: D004279:DNA, Viral; D012367:RNA, Viral; D014765:Viral Vaccines